Equities

Susmed Inc

4263:TYO

Susmed Inc

Actions
  • Price (JPY)572.00
  • Today's Change-3.00 / -0.52%
  • Shares traded65.70k
  • 1 Year change-56.90%
  • Beta--
Data delayed at least 20 minutes, as of Jun 10 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Susmed Inc is a Japan-based company mainly engaged in the digital therapeutics (DTx) development business. The Company operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.

  • Revenue in JPY (TTM)340.75m
  • Net income in JPY-358.46m
  • Incorporated2015
  • Employees33.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japaniace Co Ltd10.26bn586.21m8.70bn1.57k14.983.2614.460.8477145.09145.092,539.88667.452.41--7.246,528,126.0013.79--21.48--25.75--5.71------0.00--18.75--39.31------
Mental Health Technologies Co Ltd2.79bn57.88m8.77bn92.00203.558.5988.043.154.264.26266.68101.070.9662472.186.3830,286,890.002.01--2.65--49.81--2.08--1.8016.730.7251--14.00--66.48------
Yappli Inc5.01bn244.25m8.89bn256.0038.485.1730.361.7717.8317.83387.61132.791.7491.988.8019,587,340.008.46-27.5210.79-36.5568.9364.774.87-20.623.4065.820.3053--17.4336.6392.13---52.21--
Property Data Bank Inc2.52bn298.28m8.90bn80.0029.242.6630.053.5451.3051.30432.94564.130.639986.174.74--7.5712.588.6914.7155.9654.4211.8316.726.10--0.001622.87-11.179.24-52.397.3619.1419.14
Klab Inc9.41bn-2.55bn8.95bn572.00--0.7939--0.9513-63.05-63.05232.57259.470.4982--10.1316,447,070.00-13.49-4.58-18.58-6.2712.8418.46-27.08-4.14----0.2676---36.51-19.98-235.78---4.16--
CE Holdings Co Ltd14.36bn564.40m9.00bn610.0015.431.388.050.626837.5837.58958.70420.451.1940.273.4923,542,510.005.336.468.179.8325.1222.244.474.822.131,859.820.278727.84-0.51438.5516.9318.7724.3317.50
Ricksoft Co Ltd7.49bn269.02m9.08bn123.0033.723.2830.841.2159.1959.191,647.94608.301.42152.619.1560,906,220.005.1110.7510.1417.3329.9333.603.597.031.79--0.000.0033.2224.72-36.531.0338.17--
Susmed Inc340.75m-358.46m9.18bn33.00--1.94--26.95-21.56-21.5620.47282.530.0664--18.9110,325,700.00-6.98---7.37--96.37---105.20------0.00--67.47--78.26------
NTT DATA INTRAMART CORPORATION9.26bn350.13m9.31bn249.0026.041.8512.741.0172.1272.121,908.391,014.071.16--6.02--4.375.516.257.8039.9142.453.785.131.80--0.009135.3616.217.36-12.35-6.4014.129.73
Tripleize Co Ltd3.28bn-394.43m9.34bn242.00--14.11--2.85-57.17-57.17455.0689.641.2111.049.6813,560,150.00-14.52---27.39--28.92---12.02--1.09-31.250.7557---3.23---834.63------
Asteria Corp2.91bn-1.74bn9.36bn145.00--1.61--3.22-103.68-107.84173.20332.120.319678.4216.43---23.080.2496-28.280.302590.5883.38-72.230.82812.01--0.0736125.374.45-3.51-57.40---4.032.38
Valtes Holdings Co Ltd10.36bn518.07m9.37bn640.0017.243.1321.430.904625.3425.34506.44139.522.18--8.10--10.9213.7617.1622.6228.8928.505.005.66--472.320.26080.0014.3825.88-20.4828.4822.26--
Creo Co Ltd14.35bn717.00m9.53bn1.22k12.301.2113.850.664190.2190.211,805.67917.731.4535.704.81--7.247.199.809.9323.6223.125.004.623.21155.00--46.10-2.301.1947.231.55-1.659.86
Fabrica Holdings Co Ltd8.16bn673.53m9.61bn176.0014.282.6516.741.18123.28123.281,494.11664.101.6345.1110.43--13.4616.7618.5725.1149.0352.038.258.722.401,009.020.104418.257.4022.02-16.8643.949.78--
DreamArts Corp4.56bn409.21m9.62bn268.0022.454.8916.582.11105.70105.701,178.50485.661.42558.4813.6217,024,680.0012.71--22.78--53.84--8.97--1.9490.570.1376--20.97--233.76------
PCI Holdings Inc26.85bn834.81m9.69bn1.62k11.491.097.600.360883.3183.312,680.55881.231.5514.444.0916,562,860.005.224.788.847.6824.2025.713.363.161.67--0.107446.6413.2014.4756.7716.50-7.593.71
Data as of Jun 10 2024. Currency figures normalised to Susmed Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

10.74%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 31 Jan 2024602.20k3.60%
SPARX Asset Management Co., Ltd.as of 31 Jan 2024572.70k3.42%
Asset Management One Co., Ltd.as of 31 Jan 2024425.80k2.55%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 17 Feb 202378.00k0.47%
SBI Asset Management Co., Ltd.as of 22 Jun 202351.00k0.31%
Nikko Asset Management Co., Ltd.as of 20 Jul 202342.60k0.26%
Simplex Asset Management Co., Ltd.as of 09 May 202423.50k0.14%
Amundi Japan Ltd.as of 12 Sep 20221.50k0.01%
Norges Bank Investment Managementas of 31 Dec 20230.000.00%
More ▼
Data from 22 Jun 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.